Puerto Rico COVID-19 Vaccine Uptake Study
- Conditions
- COVID-19
- Interventions
- Other: Educational intervention
- Registration Number
- NCT05468021
- Lead Sponsor
- University of Puerto Rico
- Brief Summary
The purpose of this study is to recruit a total of 386 participants to evaluate the effectiveness of an educational program to increase the proportion of men and women aged 21 years and older who have received the COVID-19 booster vaccine
- Detailed Description
This study will address vaccine hesitancy, evaluating the intervention's efficacy in a group of vulnerable and economically disadvantaged population in PR. Randomized Clinical Trial (study design) to evaluate the effectiveness of an educational intervention to increase vaccine uptake among socioeconomically disadvantaged adults. A total sample of 386 participants will be recruited. The duration of the study will consist of 1.5 hours for intervention group and 1 hour for control group.
Eligibility criteria for the study include the following: (1) age 21 years and older, (2) resident of Puerto Rico, (3) to be fully vaccinated (received the one-dose Jansen/Johnson \& Johnson vaccine, -OR- received both doses of the two-dose Pfizer or Moderna vaccine), have not received booster doses against COVID-19, (4) no history of allergic reactions to any vaccine, (5) no history of mental health conditions that impede participation in the study, and (6) able to read, write, and understand Spanish.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 394
- age 21 years and older
- resident of Puerto Rico
- to be fully vaccinated (received the one-dose Jansen/Johnson & Johnson vaccine, -OR- received both doses of the two-dose Pfizer or Moderna vaccine)
- have not received booster doses against COVID-19
- no history of allergic reactions to any vaccine,
- no history of mental health conditions that impede participation in the study
- able to read, write, and understand Spanish.
- age 20 years and younger
- not a resident of Puerto Rico
- not to be fully vaccinated (have not received the one-dose Jansen/Johnson & Johnson vaccine, -OR- have not received both doses of the two-dose Pfizer or Moderna vaccine)
- have received booster doses against COVID-19
- history of allergic reactions to any vaccine,
- history of mental health conditions that impede participation in the study
- not be able to read, write, and understand Spanish.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention condition Educational intervention The participants in the intervention arm will receive the educational intervention after assessment.
- Primary Outcome Measures
Name Time Method Rate of COVID-10 booster vaccine uptake Up to 4 months The investigators will capture the booster vaccine administration and record the vaccine brand (Pfizer, Moderna, or Johnson \& Johnson).
Rate of COVID-19 vaccine completion Up to 4 months The investigators will record the vaccine brand of primary (Pfizer, Moderna, or Johnson \& Johnson) and capture the vaccine administration's completion (if necessary).
- Secondary Outcome Measures
Name Time Method Participant's willingness to get vaccinated against COVID-19 Up to 4 months Willingness to vaccinate against COVID-19 (vaccine confidence, vaccine convenience, vaccine complacency, and vaccine attitudes and beliefs), and receive the physician's recommendation to be vaccinated
Educational tool utilization by the participants Up to 4 months Evaluate if participant read the educational tool
Trial Locations
- Locations (2)
Outpatient Clinic, School of Medicine, University of Puerto Rico
🇵🇷San Juan, Puerto Rico
University District Hospital
🇵🇷San Juan, Puerto Rico